Jason Alan Carroll Insider Profile
4 Followers
Jason Alan Carroll, Chief Executive Officer at Tryptamine Therapeutics, holds 62.50M shares in Tryptamine Therapeutics (Ticker: AU:ENP), holds 32.07M shares in Island Pharmaceuticals Ltd (Ticker: AU:ILA). Most recently, Jason Alan Carroll Bought ― shares of Tryptamine Therapeutics on May 14, 2026 for an estimated value of AU$45.60K.
Jason Alan Carroll's Trading History
You May Also Like
Jason Alan Carroll insider profile FAQ
What is the percentage of profitable transactions made by Jason Alan Carroll?
The percentage of profitable transactions made by Jason Alan Carroll is 17%.
What is the average return per transaction made by Jason Alan Carroll?
The average return per transaction made by Jason Alan Carroll is 18.30%.
What stocks does Jason Alan Carroll hold?
Jason Alan Carroll holds: AU:ENP, AU:ILA stocks.
What was Jason Alan Carroll’s latest transaction?
Jason Alan Carroll’s latest transaction was an Informative Buy of AU$45.60K.
What was Jason Alan Carroll's most profitable transaction?
Jason Alan Carroll’s most profitable transaction was an Informative Buy of AU:ILA stock on July 25, 2025. The return on the trade was 166.60%.
What is Jason Alan Carroll's role in Tryptamine Therapeutics?
Jason Alan Carroll's role in Tryptamine Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
